WO2000000593A3 - Sphingolipid-desaturase - Google Patents

Sphingolipid-desaturase Download PDF

Info

Publication number
WO2000000593A3
WO2000000593A3 PCT/DE1999/001859 DE9901859W WO0000593A3 WO 2000000593 A3 WO2000000593 A3 WO 2000000593A3 DE 9901859 W DE9901859 W DE 9901859W WO 0000593 A3 WO0000593 A3 WO 0000593A3
Authority
WO
WIPO (PCT)
Prior art keywords
enzymes
sphingolipids
capnoids
sphingobase
dna sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE1999/001859
Other languages
English (en)
French (fr)
Other versions
WO2000000593A2 (de
Inventor
Ernst Heinz
Ulrich Zaehringer
Petra Sperling
Hermann Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GVS Gesellschaft fuer Verwertungssysteme GmbH
Original Assignee
GVS Gesellschaft fuer Verwertungssysteme GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GVS Gesellschaft fuer Verwertungssysteme GmbH filed Critical GVS Gesellschaft fuer Verwertungssysteme GmbH
Priority to AU54075/99A priority Critical patent/AU5407599A/en
Publication of WO2000000593A2 publication Critical patent/WO2000000593A2/de
Publication of WO2000000593A3 publication Critical patent/WO2000000593A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083—Miscellaneous (1.14.99)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Plant Pathology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Die Erfindung betrifft Enzyme, die selektiv eine Doppelbindung in die Sphingobase des Ceramidrestes von Sphingolipiden und von Capnoiden einführen und für diese Enzyme kodierende DNA-Sequenzen. Die Erfindung betrifft weiterhin die Verwendung der Enzyme und DNA-Sequenzen zur Veränderung des Gehaltes und/oder der Struktur von Sphingolipiden, deren Katabolite und/oder deren synthetischer Folgeprodukte in transgenen Zellen und/oder Organismen. Weiterhin wird ein Verfahren zur Herstellung von Sphingolipiden und von Capnoiden mit ungesättigter Sphingobase offenbart.
PCT/DE1999/001859 1998-06-27 1999-06-25 Sphingolipid-desaturase Ceased WO2000000593A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU54075/99A AU5407599A (en) 1998-06-27 1999-06-25 Sphingolipid-desaturase

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19828850.6 1998-06-27
DE19828850A DE19828850A1 (de) 1998-06-27 1998-06-27 Sphingolipid-Desaturase

Publications (2)

Publication Number Publication Date
WO2000000593A2 WO2000000593A2 (de) 2000-01-06
WO2000000593A3 true WO2000000593A3 (de) 2000-08-10

Family

ID=7872312

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1999/001859 Ceased WO2000000593A2 (de) 1998-06-27 1999-06-25 Sphingolipid-desaturase

Country Status (3)

Country Link
AU (1) AU5407599A (de)
DE (1) DE19828850A1 (de)
WO (1) WO2000000593A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106754769A (zh) * 2016-12-01 2017-05-31 中国科学院华南植物园 一种番茄抗冷害基因及应用

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10030976A1 (de) * 2000-06-30 2002-01-10 Basf Ag DELTA6-Desaturasegene exprimierende Pflanzen und PUFAS enthaltende Öle aus diesen Pflanzen und ein Verfahren zur Herstellung ungesättigter Fettsäuren
CA2432978C (en) 2000-12-22 2012-08-28 Medlyte, Inc. Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
JP4737531B2 (ja) * 2005-12-05 2011-08-03 サントリーホールディングス株式会社 形質転換酵母を用いるセラミドの製造方法
US9274130B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Prevention and treatment of pain using antibodies to lysophosphatidic acid
US9274129B2 (en) 2006-05-31 2016-03-01 Lpath, Inc. Methods and reagents for detecting bioactive lipids
US9217749B2 (en) 2006-05-31 2015-12-22 Lpath, Inc. Immune-derived moieties reactive against lysophosphatidic acid
PL2087002T3 (pl) 2006-10-27 2015-02-27 Lpath Inc Kompozycje i sposoby do wiązania sfingozyno-1 fosforanu
US8871202B2 (en) 2008-10-24 2014-10-28 Lpath, Inc. Prevention and treatment of pain using antibodies to sphingosine-1-phosphate
US10045499B2 (en) * 2012-05-24 2018-08-14 Iowa State University Research Foundation, Inc. Arabidopsis nonhost resistance gene(s) and use thereof to engineer disease resistant plants

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996021022A2 (en) * 1994-12-30 1996-07-11 Rhone-Poulenc Agrochimie Production of gamma linolenic acid by a δ6-desaturase

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996021022A2 (en) * 1994-12-30 1996-07-11 Rhone-Poulenc Agrochimie Production of gamma linolenic acid by a δ6-desaturase

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
NAPIER, J. A. (1) ET AL: "Cytochrome b5 fusion proteins: A new class of higher plant fatty acid desaturases.", JOURNAL OF EXPERIMENTAL BOTANY, (MAY, 1998) VOL. 49, NO. SUPPL., PP. 15. MEETING INFO.: THE SOCIETY FOR EXPERIMENTAL BIOLOGY ANNUAL MEETING LONDON, ENGLAND, UK MARCH 22-27, 1998 SOCIETY FOR EXPERIMENTAL BIOLOGY., XP002132573 *
SCHMIDT, HERMANN (1) ET AL: "Purification and PCR-based cDNA cloning of a plastidial n-6 desaturase.", PLANT MOLECULAR BIOLOGY, (1994) VOL. 26, NO. 2, PP. 631-642., XP002132574 *
SPERLING, PETRA ET AL: "A cytochrome-b5-containing fusion protein similar to plant acyl lipid desaturases", EUR. J. BIOCHEM. (1995), 232(3), 798-805, XP002132571 *
SPERLING, PETRA ET AL: "A sphingolipid desaturase from higher plants. Identification of a new cytochrome b5 fusion protein", J. BIOL. CHEM., 273(44), 28590-28596, 30 October 1998 (1998-10-30), XP002132572 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106754769A (zh) * 2016-12-01 2017-05-31 中国科学院华南植物园 一种番茄抗冷害基因及应用
CN106754769B (zh) * 2016-12-01 2019-08-23 中国科学院华南植物园 一种番茄抗冷害基因及应用

Also Published As

Publication number Publication date
WO2000000593A2 (de) 2000-01-06
DE19828850A1 (de) 1999-12-30
AU5407599A (en) 2000-01-17

Similar Documents

Publication Publication Date Title
WO1999047649A3 (de) Polymerasenchimären
EP1700915A3 (de) Enzymatische DNS-Moleküle
EP0712862A3 (de) Selektive Acylierung von Epsilon-Aminogruppen
ID18631A (id) Proses pembuatan asam l-amino melalui fermentasi
AU2002210991A1 (en) Novel glucose dehydrogenase and process for producing the dehydrogenase
WO1998008974A3 (en) Catalytic nucleic acid and its medical use
CA2316808A1 (en) Transgenic rabbit that expresses a functional human lipoprotein (a)
WO2004015085A3 (en) Method and compositions relating to 5’-chimeric ribonucleic acids
EP0678576A3 (de) Fructosyl-Aminosäureoxidase und Verfahren zu deren Herstellung.
WO2000000593A3 (de) Sphingolipid-desaturase
WO2001058934A3 (en) Kahalalide f and related compounds
DE69519638D1 (de) Verfahren zur Herstellung von Alpha-Hydroxysäuren oder Alpha-Hydroxyamiden durch Mikroorganismen
ATE303070T1 (de) Herstellung von nahrungsmitteln durch fermentierung von sojamilch mit streptococcus thermophilus
CA2187250A1 (en) Method for Producing a Soluble Protein with Bacteria
DE69629299D1 (de) Prozess für die produktion von l-lysin durch fermentation
ATE457354T1 (de) Für ein a. thaliana protein kodierende dna- sequenz mit delta-5,7-sterol-delta-7- reduktaseaktivität, das protein, verfahren zur herstellung, transformierte hefe-stämme und verwendungen
WO2001016362A3 (de) Fettsäure-desaturase-gen aus pflanzen
WO1997009420A3 (en) Dna sequences coding for a human metalloproteinase and variants thereof
CA2173115A1 (en) Genes for butyrobetaine/crotonobetaine-l-carnitine metabolism and their use for the microbiological production of l-carnitine
EP0736604A3 (de) Materialien und Verfahren zur Herstellung von D-Phenylalanin
WO2000001841A3 (en) Hyaluronic acid mimics and methods related thereto
WO1998039458A8 (en) Process for preparing doxorubicin
EP0620439A3 (en) Method of determining the binding of transcription factors to nucleic acids.
WO2002033065A3 (fr) Procede de production de proteines par electropulsation
ZA996751B (en) Process for the fermentative production of L-amino acids.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU BR CA CN CZ HU JP MX PL US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU BR CA CN CZ HU JP MX PL US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase